Current best evidence on prescribed drugs

Drugdocs Logo

Current best evidence on prescribed drugs

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Xadago

Chemical Namesafinamide
Dosage FormTablet (oral; 50 mg, 100 mg)
Drug ClassInhibitors
SystemMusculoskeletal, Nervous
CompanySupernus Pharmaceuticals
Approval Year2017

Indication

  • Indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes
Last updated on 4/21/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xadago (Safinamide) Prescribing Information.2017US WorldMeds, LLC, Louisville, KY
Document TitleYearSource
Clinical review report: safinamide (Onstryv). 2020CADTH
Pharmacoeconomic review report: safinamide (Onstryv).2020CADTH
Australian public assessment report for safinamide. 2019Australian Government: Department of Health
Parkinson’s disease with motor fluctuations: safinamide. 2017NICE
Document TitleYearSource
Overall efficacy and safety of safinamide in Parkinson’s disease: a systematic review and a meta‑analysis. 2021Clinical Drug Investigation
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis.2020European Journal of Clinical Pharmacology
A systematic review and meta-analysis of safety and efficacy of safinamide for motor fluctuations in patients with Parkinson's disease. 2019F1000Research
Comprehensive examination of therapies for pain in Parkinson’s disease: a systematic review and meta-analysis. 2018Neuroepidemiology
A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease. 2018British Journal of Clinical Pharmacology
Document TitleYearSource
A Spanish consensus on the use of safinamide for Parkinson’s disease in clinical practice. 2020Brain Sciences